ID: ALA3983514

Max Phase: Preclinical

Molecular Formula: C11H8N4O3

Molecular Weight: 244.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(/C=C/c1ccc([N+](=O)[O-])cc1)c1c[nH]nn1

Standard InChI:  InChI=1S/C11H8N4O3/c16-11(10-7-12-14-13-10)6-3-8-1-4-9(5-2-8)15(17)18/h1-7H,(H,12,13,14)/b6-3+

Standard InChI Key:  GWCZBIMTBRUMMV-ZZXKWVIFSA-N

Associated Targets(non-human)

Protein-glutamine gamma-glutamyltransferase 2 55 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 244.21Molecular Weight (Monoisotopic): 244.0596AlogP: 1.61#Rotatable Bonds: 4
Polar Surface Area: 101.78Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.58CX Basic pKa: CX LogP: 2.14CX LogD: 1.92
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.38Np Likeness Score: -1.05

References

1.  (2015)  Cinnamoyl inhibitors of transglutaminase, 

Source

Source(1):